维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="Wanstall JC"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension 显示文摘	Wanstall JC	2001	Pharmacol Ther2001，92，1：	1
2	Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension 显示文摘	Jeffery TK Wanstall JC	2001	Pharmacol Ther2001，92，1：	1
3	The pulmonary vasodilator properties of potassium channel opening drugs显示文摘	Wanstall JC	1996	Gen Pharmacol1996，27，：	1
4	Pulmonary vascular remodeling:a target for therapeutic intervention in pulmonary hypertension 显示文摘	Jeffery TK Wanstall JC	2001	Phar- macol Ther2001，92，1：	1
5	Pulmonary vascular remodeling in hypoxic rats: effects of amlodipine,along and with perindopril显示文摘	Jeffery TK Wanstall JC	2001	Eur J Pharmacol2001，416，12：	1
6	Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension 显示文摘	Jeffery TK Wanstall JC	2001	Pharmacol Ther2001，92，1：	1
7	Recognition and management of pulmonary hypertension 显示文摘	Wanstall JC Jeffery TK	1998	Drugs1998，56，6：	1
8	Recognition and management of pulmonary hypertension显示文摘	WANSTALL JC JEFFERY TK	1998	Drugs1998，56，6：	1
9	Vascular chymase:pathophysiological role and therapeutic potential of inhibition显示文摘	Doggrell SA Wanstall JC	2004	Cardiovase Res2004，61，4：	1
10	Vascular chymase pathophysiological role and therapeutic potential of inhibition 显示文摘	Doggrell SA Wanstall JC	2004	Cardiovasc Res2004，61，4：	1
11	Cardiac ehymase : pathophysiological role and therapeutic potential of chymase inhibitors 显示文摘	Doggrell SA Wanstall JC	2005	Can J Physiol Pharmacol2005，83，2：	1
12	Increased relaxation by feldipine o n pulmonary artery from rats with monocrotaline-induced pulmonary hypertension dose not reflect functional impairment of the endothelim显示文摘	O'Donnell SR Kay CS	1991	Pulmon Pharmacol1991，4，1：	1
13	Pulmonary vascular remodeling:a target for therapeutic intervention in pulmonary hypertension显示文摘	Jeffery TK Wanstall JC	2001	Pharmacol Ther2001，92，1：	1
14	Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors 显示文摘	Doggrell SA Wanstall JC	2005	Can J Physiol Pharmacol2005，83，2：	1
15	Vascular chymase: pathophysiological role and therapeutic potential of inhibition 显示文摘	Doggrell SA Wanstall JC	2004	Cardiovasc Res2004，61，4：	1
16	Will chymase inhibitors be the next major development for the treatment of cardiovascular disorders? 显示文摘	Doggrell SA Wanstall JC	2003	Expert Opin Investig Drugs2003，12，8：	1
17	Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension显示文摘	Jeffery TK Wanstall JC	2001	Pharmacol Ther2001，92，：	1
18	Pulmonary vascular remodeling:a target for therapeutic intervention in pulmonary hypertension 显示文摘	Jeffry TK Wanstal JC	2001	Pharmacol Ther2001，92，1：	1
19	Pulmonary vascular remodeling: atarget for therapeutic intervention in pulmonary hypertension显示文摘	Jeffery TK Wanstall JC	2002	Pharmacol Ther2002，92，1：	1
20	Beta1 and beta2 adrenoceptor-mediated response in preparationof pulmonary artery and aorta from young and aged rats显示文摘	Wanstall JC	1984	J Pharmacol Exp Ther1984，228，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示